Brief: Nkarta Presents Preclinical Data Exploring Gene Knockout Strategies And Combination Agents With Nk Cell-Based Therapies At The 2023 Aacr Annual Meeting
17/04/2023 22:53
April 17 (Reuters) - Nkarta Inc NKTX.O :
* NKARTA PRESENTS PRECLINICAL DATA EXPLORING GENE KNOCKOUT
STRATEGIES AND COMBINATION AGENTS WITH NK CELL-BASED THERAPIES
AT THE 2023 AACR ANNUAL MEETING
Source text for Eikon: ID:nGNX5GWdrN
Further company coverage: NKTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nkarta
See all newsNkarta, Inc. reports results for the quarter ended June 30 - Earnings Summary
Biotech firm Nkarta posts Q2 net loss; cash runway into 2029
Brief: Nkarta Q2 EPS USD -0.54
Nkarta, Inc. expected to post a loss of 38 cents a share - Earnings Preview
Biotech experts want FDA drug reviews based on science, not politics (updated)